LifeNet Health Launches OraGen Bone Allograft for Dental Procedures

LifeNet Health launched OraGen, the first viable dental bone allograft comprised of cryopreserved corticocancellous bone containing endogenous lineage-committed bone cells combined with demineralized bone matrix. 

The OraGen composition delivers three essential properties for bone regeneration: osteogenicity, with lineage-committed bone cells that produce new bone; osteoconductivity, providing a biocompatible scaffold for cell attachment and growth; and osteoinduction, which stimulates bone repair through retained natural growth factors. 

“Salvin Dental’s exclusive distribution agreement with LifeNet Health for OraGen demonstrates our unwavering commitment to providing the most comprehensive and innovative regenerative solutions to our customers,” said Ken Serota, CEO of Young Innovations. “Salvin’s enduring partnership with LifeNet Health has consistently focused on enhancing patient outcomes through a dedication to quality and service. Together, we look forward to empowering dental surgeons to improve their patients’ quality of life.” 

OraGen undergoes rigorous aseptic processing and features a proprietary cryopreservation method that maximizes cell viability by processing grafts within 72 hours. OraGen also thaws in under five minutes, ensuring quick and easy preparation in clinical settings.

OraGen is designed for use in dental procedures, including sinus and ridge augmentation and repairing large defects in the mandible or maxilla. It enables rapid new bone formation immediately after implantation and sustained growth over time.

OraGen is now available in the U.S. through LifeNet Health’s strategic partner, Salvin Dental Specialties, a trusted leader in dental surgical products. Tailored for advanced dental procedures, OraGen offers transformative potential for dental surgeons and their patients.

“We are thrilled to collaborate with Salvin Dental Specialties to introduce OraGen to the market,” said Daniel Osborne, Chief Growth Officer at LifeNet Health. “This partnership reflects our commitment to delivering cutting-edge solutions that not only drive better patient outcomes but also advance the field of regenerative medicine. Together, we’re not just facilitating healing; we’re improving lives.”